Search

Search Constraints

You searched for: Author/Creator Wilson, R H

Search Results

3. Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer. (17th July 2018)